Definition of constitutive and stage-enriched promoters in the rodent malaria parasite, Plasmodium yoelii.


Journal

Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802

Informations de publication

Date de publication:
23 Nov 2020
Historique:
received: 29 06 2020
accepted: 15 11 2020
entrez: 24 11 2020
pubmed: 25 11 2020
medline: 22 6 2021
Statut: epublish

Résumé

Well-defined promoters are essential elements for genetic studies in all organisms, and enable controlled expression of endogenous genes, transgene expression, and gene editing. Despite this, there is a paucity of defined promoters for the rodent-infectious malaria parasites. This is especially true for Plasmodium yoelii, which is often used to study the mosquito and liver stages of malarial infection, as well as host immune responses to infection. Here six promoters were selected from across the parasite's life cycle (clag-a, dynein heavy chain delta, lap4, trap, uis4, lisp2) that have been invoked in the literature as controlling their genes in a stage-specific manner. A minimal promoter length for the constitutive pybip promoter that confers strong expression levels was also determined, which is useful for expression of reporters and gene editing enzymes. Instead, it was observed that these promoters confer stage-enriched gene control, as some parasites also effectively use these promoters in other stages. Thus, when used alone, these promoters could complicate the interpretation of results obtained from promoter swaps, stage-targeted recombination, or gene editing experiments. Together these data indicate that achieving stage-specific effects, such as gene editing, is likely best done using a two-component system with independent promoter activities overlapping only in the intended life cycle stage.

Sections du résumé

BACKGROUND BACKGROUND
Well-defined promoters are essential elements for genetic studies in all organisms, and enable controlled expression of endogenous genes, transgene expression, and gene editing. Despite this, there is a paucity of defined promoters for the rodent-infectious malaria parasites. This is especially true for Plasmodium yoelii, which is often used to study the mosquito and liver stages of malarial infection, as well as host immune responses to infection.
METHODS METHODS
Here six promoters were selected from across the parasite's life cycle (clag-a, dynein heavy chain delta, lap4, trap, uis4, lisp2) that have been invoked in the literature as controlling their genes in a stage-specific manner. A minimal promoter length for the constitutive pybip promoter that confers strong expression levels was also determined, which is useful for expression of reporters and gene editing enzymes.
RESULTS RESULTS
Instead, it was observed that these promoters confer stage-enriched gene control, as some parasites also effectively use these promoters in other stages. Thus, when used alone, these promoters could complicate the interpretation of results obtained from promoter swaps, stage-targeted recombination, or gene editing experiments.
CONCLUSIONS CONCLUSIONS
Together these data indicate that achieving stage-specific effects, such as gene editing, is likely best done using a two-component system with independent promoter activities overlapping only in the intended life cycle stage.

Identifiants

pubmed: 33228734
doi: 10.1186/s12936-020-03498-w
pii: 10.1186/s12936-020-03498-w
pmc: PMC7685602
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

424

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI123341
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : 1R01AI123341

Références

Mol Microbiol. 2014 Mar;91(6):1200-13
pubmed: 24446886
PLoS One. 2011;6(12):e29289
pubmed: 22216235
Mol Biochem Parasitol. 2001 Apr 6;113(2):271-8
pubmed: 11295181
J Biol Chem. 2002 Nov 1;277(44):41948-53
pubmed: 12177071
Cell Microbiol. 2013 Sep;15(9):1508-1526
pubmed: 23421981
Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):3022-7
pubmed: 15699336
PLoS Pathog. 2010 Feb 12;6(2):e1000767
pubmed: 20169188
Mol Biochem Parasitol. 2004 Sep;137(1):13-21
pubmed: 15279947
PLoS Biol. 2003 Oct;1(1):E5
pubmed: 12929205
Cell Host Microbe. 2012 Jul 19;12(1):9-19
pubmed: 22817984
Cell Host Microbe. 2015 Apr 8;17(4):526-35
pubmed: 25800544
Sci Rep. 2016 May 31;6:26824
pubmed: 27241521
Nucleic Acids Res. 2006 Feb 21;34(4):1166-73
pubmed: 16493140
Mol Microbiol. 2017 Oct;106(2):266-284
pubmed: 28787542
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18640-5
pubmed: 20921402
PLoS Pathog. 2019 Jan 31;15(1):e1007164
pubmed: 30703164
PLoS One. 2015 Apr 15;10(4):e0123473
pubmed: 25874388
Nat Protoc. 2006;1(2):614-23
pubmed: 17406288
Mol Microbiol. 2013 May;88(4):687-701
pubmed: 23489321
mBio. 2014 Jul 01;5(4):e01414-14
pubmed: 24987097
Int J Parasitol. 2011 Jan;41(1):117-23
pubmed: 20816845
Curr Opin Microbiol. 2018 Dec;46:93-101
pubmed: 30317152
Mol Biochem Parasitol. 2006 Apr;146(2):242-50
pubmed: 16458371
Cell. 1997 Aug 8;90(3):511-22
pubmed: 9267031
EMBO J. 1995 Aug 15;14(16):3883-94
pubmed: 7664729
J Clin Invest. 2012 Oct;122(10):3618-28
pubmed: 22996664
Mol Microbiol. 2014 Feb;91(4):679-93
pubmed: 24330260
Nat Biotechnol. 2014 Aug;32(8):819-21
pubmed: 24880488
Mol Microbiol. 2013 Jan;87(1):66-79
pubmed: 23216750
Science. 1995 Jun 2;268(5215):1358-62
pubmed: 7761856
PLoS Pathog. 2018 Aug 22;14(8):e1007249
pubmed: 30133543
Nat Commun. 2019 Oct 31;10(1):4964
pubmed: 31673027
Cell Microbiol. 2009 Aug;11(8):1272-88
pubmed: 19438517
Mol Biochem Parasitol. 2017 Mar;212:1-8
pubmed: 28034675
Science. 2019 Aug 23;365(6455):
pubmed: 31439762
Infect Immun. 2014 Nov;82(11):4643-53
pubmed: 25156733
Elife. 2019 May 16;8:
pubmed: 31094679
Nat Commun. 2018 Jul 9;9(1):2656
pubmed: 29985403
J Biol Chem. 2019 Feb 8;294(6):2098-2108
pubmed: 30563838
Mol Cell Proteomics. 2016 Sep;15(9):2852-62
pubmed: 27371728
Brief Funct Genomics. 2019 Sep 24;18(5):281-289
pubmed: 31365053
J Biol Chem. 2019 Jun 14;294(24):9555-9566
pubmed: 31043479

Auteurs

Laura M Bowman (LM)

Department of Biochemistry and Molecular Biology, The Huck Center for Malaria Research, Pennsylvania State University, University Park, PA, USA.

Logan E Finger (LE)

Department of Biochemistry and Molecular Biology, The Huck Center for Malaria Research, Pennsylvania State University, University Park, PA, USA.

Kevin J Hart (KJ)

Department of Biochemistry and Molecular Biology, The Huck Center for Malaria Research, Pennsylvania State University, University Park, PA, USA.

Scott E Lindner (SE)

Department of Biochemistry and Molecular Biology, The Huck Center for Malaria Research, Pennsylvania State University, University Park, PA, USA. Scott.Lindner@psu.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH